Hansoh Pharmaceutical Group Company Limited (HKG:3692)
34.94
-0.40 (-1.13%)
Sep 23, 2026, 4:08 PM HKT
HKG:3692 Market Cap
HKG:3692 has a market cap or net worth of 211.84 billion as of September 23, 2026. Its market cap has decreased by -1.04% in one year.
Market Cap
211.84B
Enterprise Value
173.57B
Revenue
18.35B
Ranking
n/a
PE Ratio
27.32
Stock Price
34.94
ChartMarket Cap Chart
Since June 14, 2019, HKG:3692's market cap has increased from 111.27B to 211.84B, an increase of 90.39%. That is a compound annual growth rate of 9.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 211.84B | -3.02% |
| Dec 31, 2025 | 218.43B | 113.01% |
| Dec 31, 2024 | 102.55B | 9.84% |
| Dec 29, 2023 | 93.36B | 6.25% |
| Dec 30, 2022 | 87.86B | -21.92% |
| Dec 31, 2021 | 112.52B | -49.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 29.82B |
| China Resources Pharmaceutical Group | 27.52B |
| China Medical System Holdings | 27.08B |
| Sunshine Lake Pharma | 22.53B |
| Grand Pharmaceutical Group | 17.26B |
| The United Laboratories International Holdings | 16.06B |
| Fujian Haixi Pharmaceuticals | 14.50B |
| CanSino Biologics | 13.45B |